"In vitro" study of sulfimidazole, trimethoprim and fluoroquinolones in traveller's bowel infections.
Castelli
M
M
University of Modena, Inst. of Pharmacol.
Baggio
G
G
Ruberto
A I
AI
Provvisionato
A
A
Malagoli
M
M
Bossa
R
R
Galatulas
I
I
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy / Q000382:microbiology; D005759:Gastroenteritis / Q000188:drug therapy / Q000382:microbiology; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D006801:Humans; D008826:Microbial Sensitivity Tests; D009593:Nitroimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D009643:Norfloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use; D014195:Travel; D014295:Trimethoprim / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D009593:Nitroimidazoles; D013449:Sulfonamides; C061005:1-methyl-2-((4-aminophenyl)sulfonyl)amino-5-nitroimidazole; D002939:Ciprofloxacin; D014295:Trimethoprim; D009643:Norfloxacin